{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:54:41Z","timestamp":1783976081040,"version":"3.55.0"},"reference-count":54,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science, Technology and Innovation (MINCIENCIAS)","award":["722-2021"],"award-info":[{"award-number":["722-2021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Docetaxel is extensively used for treating different types of cancer; however, its clinical efficacy is primarily limited by myelotoxicity and peripheral neuropathy, adverse effects that often lead to treatment discontinuation. This study aimed to establish a preclinical model in Wistar rats for the simultaneous induction of myelotoxicity and peripheral neuropathy associated with docetaxel administration, enabling the evaluation of potential chemopreventive agents. Four distinct docetaxel administration schemes were assessed by performing behavioral nociceptive tests and complete blood cell counts. After establishing the damage model (5 mg\/kg\/week docetaxel for six weeks), we co-administered 100 mg\/kg\/week oral dimethyl fumarate to assess its protective effect. Dimethyl fumarate attenuated docetaxel-induced hyperalgesia, likely through preserving normal nerve fiber density in sciatic nerves, but neutropenia was not significantly mitigated. An alternative regimen with additional pre-administered doses of dimethyl fumarate showed a trend toward neutropenia attenuation and suggested an interesting inhibition of docetaxel-induced rat vibrissae loss. Chou-Talalay isobolographic analyses on prostate cancer cell lines revealed that dimethyl fumarate does not impair the therapeutic effect of docetaxel at most combination ratios evaluated; rather, synergistic effects were observed. This experimental model proved useful and will facilitate further research into the protective role of dimethyl fumarate and other potential chemoprotective agents.<\/jats:p>","DOI":"10.3390\/ijms26125859","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T06:11:07Z","timestamp":1750313467000},"page":"5859","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["An Experimental Rat Model for Simultaneous Induction of Peripheral Neuropathy and Myelotoxicity by Docetaxel Administration: Evaluating the Protective Role of Dimethyl Fumarate"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5868-7063","authenticated-orcid":false,"given":"Sebastian","family":"Cubides-Cely","sequence":"first","affiliation":[{"name":"Pharmacology and Metabolism Research Laboratory, Universidad Industrial de Santander, Bucaramanga 68002, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7384-4990","authenticated-orcid":false,"given":"Alexander","family":"David Castro","sequence":"additional","affiliation":[{"name":"Pharmacology and Metabolism Research Laboratory, Universidad Industrial de Santander, Bucaramanga 68002, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Prado-Guevara","sequence":"additional","affiliation":[{"name":"Pharmacology and Metabolism Research Laboratory, Universidad Industrial de Santander, Bucaramanga 68002, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C\u00e9sar","family":"Mantilla-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Department of Pathology, Universidad Industrial de Santander, Bucaramanga 68002, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2370-1841","authenticated-orcid":false,"given":"Mario","family":"Negrette-Guzm\u00e1n","sequence":"additional","affiliation":[{"name":"Pharmacology and Metabolism Research Laboratory, Universidad Industrial de Santander, Bucaramanga 68002, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.46.1.108","article-title":"Peripheral neuropathy secondary to docetaxel (Taxotere)","volume":"46","author":"New","year":"1996","journal-title":"Neurology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.7150\/thno.73152","article-title":"Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.1995.13.10.2643","article-title":"Docetaxel","volume":"13","author":"Cortes","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/1008-682X.122593","article-title":"Chemotherapy and its evolving role in the management of advanced prostate cancer","volume":"16","author":"Schweizer","year":"2014","journal-title":"Asian J. Androl."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/CMAR.S40601","article-title":"Presentation and management of docetaxel-related adverse effects in patients with breast cancer","volume":"6","author":"Ho","year":"2014","journal-title":"Cancer Manag. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.3390\/curroncol31090423","article-title":"Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention","volume":"31","author":"Perez","year":"2024","journal-title":"Curr. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/toxics3020152","article-title":"Taxane-induced peripheral neurotoxicity","volume":"3","author":"Velasco","year":"2015","journal-title":"Toxics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1200\/JCO.24.00526","article-title":"ECOG-ACRIN EAZ171: Prospective Validation Trial of Germline Predictors of Taxane-Induced Peripheral Neuropathy in Black Women with Early-Stage Breast Cancer","volume":"42","author":"Schneider","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Desforges, A.D., Hebert, C.M., Spence, A.L., Reid, B., Dhaibar, H.A., Cruz-Topete, D., Cornett, E.M., Kaye, A.D., Urits, I., and Viswanath, O. (2022). Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update. Biomed. Pharmacother., 147.","DOI":"10.1016\/j.biopha.2022.112671"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMOeEONSeEANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2145446","DOI":"10.1001\/jamanetworkopen.2021.45446","article-title":"Efficacy of Plinabulin vs Pegfilgrastim for Prevention of Docetaxel-Induced Neutropenia in Patients with Solid Tumors: A Randomized Clinical Trial","volume":"5","author":"Blayney","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOH.0000000000000208","article-title":"How I diagnose and treat neutropenia","volume":"23","author":"Dale","year":"2016","journal-title":"Curr. Opin. Hematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/SPC.0b013e32832ea6ae","article-title":"Advances in the treatment of neutropenia","volume":"3","author":"Dale","year":"2009","journal-title":"Curr. Opin. Support. Palliat. Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4174\/astr.2018.94.5.223","article-title":"Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy","volume":"94","author":"Lee","year":"2018","journal-title":"Ann. Surg. Treat. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00280-019-03998-w","article-title":"Plinabulin ameliorates neutropenia induced by multiple chemotherapies through a mechanism distinct from G-CSF therapies","volume":"85","author":"Tonra","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/liv.14483","article-title":"Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease","volume":"40","author":"Sangineto","year":"2020","journal-title":"Liver Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/ALN.0000000000003077","article-title":"Oral dimethyl fumarate reduces peripheral neuropathic pain in rodents via NFe2L2 antioxidant signaling","volume":"132","author":"Jiahe","year":"2020","journal-title":"Anesthesiology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Sanz, A., Coronado-Albi, M.J., Mu\u00f1oz-Viana, R., Garc\u00eda-Merino, A., and S\u00e1nchez-L\u00f3pez, A.J. (2024). Neuroprotective and Anti-Inflammatory Effects of Dimethyl Fumarate, Monomethyl Fumarate, and Cannabidiol in Neurons and Microglia. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252313082"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Al-Jaderi, Z., and Maghazachi, A.A. (2016). Utilization of dimethyl fumarate and related molecules for treatment of multiple sclerosis, cancer, and other diseases. Front. Inmunol., 7.","DOI":"10.3389\/fimmu.2016.00278"},{"key":"ref_21","first-page":"e28818","article-title":"Dimethyl Fumarate Ameliorates Paclitaxel-Induced Neuropathic Pain in Rats","volume":"14","author":"Singh","year":"2022","journal-title":"Cureus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41419-025-07412-7","article-title":"Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma","volume":"16","author":"Dai","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Barut, E.N., Engin, S., \u00d6z, E., and Reis, R. (2025). Dimethyl Fumarate Attenuates Cyclophosphamide-Induced Bladder Damage and Enhances Cytotoxic Activity Against SH-SY5Y Cells. J. Biochem. Mol. Toxicol., 39.","DOI":"10.1002\/jbt.70212"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood.2022018669","article-title":"Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: A multicenter phase 2 study","volume":"142","author":"Nicolay","year":"2023","journal-title":"Blood"},{"key":"ref_25","first-page":"1","article-title":"Hematological and biochemical parameters in Sprague Dawley laboratory rats breed in CENPALAB, Cenp: SPRD","volume":"12","author":"Blanco","year":"2011","journal-title":"Rev. Electron. Vete."},{"key":"ref_26","unstructured":"Giknis, M.L.A., and Clifford, C.B. (2008). Clinical Laboratory Parameters for CrI: WI (Han) Rats, Charles River Laboratories."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41391-021-00326-3","article-title":"Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: A pooled analysis of open phase 3 clinical trial data","volume":"24","author":"Martini","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s11095-010-0180-0","article-title":"Evaluation of docetaxel-loaded intravenous lipid emulsion: Pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity","volume":"27","author":"Zhao","year":"2010","journal-title":"Pharm. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/01480545.2017.1390580","article-title":"Phosphatidylcholine attenuated docetaxel-induced peripheral neurotoxicity in rats","volume":"41","author":"Kim","year":"2018","journal-title":"Drug Chem. Toxicol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2169\/internalmedicine.5089-20","article-title":"A multicenter study of docetaxel at a dose of 100 mg\/m2 in japanese patients with advanced or recurrent breast cancer","volume":"60","author":"Hirata","year":"2021","journal-title":"Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1038\/aps.2018.16","article-title":"Combined treatment with apatinib and docetaxel in A549 xenograft mice and its cellular pharmacokinetic basis","volume":"39","author":"Feng","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.1998.16.10.3426","article-title":"Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment","volume":"16","author":"Semb","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Deuis, J.R., Dvorakova, L.S., and Vetter, I. (2017). Methods used to evaluate pain behaviors in rodents. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00284"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ctrv.2015.10.010","article-title":"Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: A systematic review","volume":"41","author":"Frederiks","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.trsl.2006.05.007","article-title":"Vitamin E but not St. John\u2019s wort mitigates leukopenia caused by cancer chemotherapy in rats","volume":"148","author":"Branda","year":"2006","journal-title":"Transl. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1248\/bpb.b18-00855","article-title":"Dimethyl Fumarate Attenuates Oxaliplatin-Induced Peripheral Neuropathy without Affecting the Anti-tumor Activity of Oxaliplatin in Rodents","volume":"42","author":"Miyagi","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ejca.2005.04.006","article-title":"Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats","volume":"41","author":"Persohn","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jphs.2018.06.008","article-title":"Dimethyl fumarate ameliorates chemotherapy agent-induced neurotoxicity in vitro","volume":"137","author":"Kawashiri","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4103\/ijp.ijp_540_24","article-title":"Dimethyl fumarate improves nuclear factor erythroid-related factor 2-mediated antioxidant response to ameliorate functional and molecular deficits in experimental diabetic neuropathy","volume":"56","author":"Jindam","year":"2024","journal-title":"Indian J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/COC.0000000000001153","article-title":"Evaluating N-acetylcysteine as a Protective Agent Against Chemotherapy-induced Neuropathy in Breast Cancer","volume":"48","author":"Hassanzadeh","year":"2025","journal-title":"Am. J. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Petrikonis, K., Bernatoniene, J., Kopustinskiene, D.M., Casale, R., Davinelli, S., and Saso, L. (2024). The Antinociceptive Role of Nrf2 in Neuropathic Pain: From Mechanisms to Clinical Perspectives. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16081068"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1158\/0008-5472.CAN-15-3116","article-title":"Structural basis for induction of peripheral neuropathy by microtubule-targeting cancer drugs","volume":"76","author":"Smith","year":"2016","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00520-013-1804-9","article-title":"Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment","volume":"21","author":"Betticher","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jid.2016.08.035","article-title":"Oxidative Damage Control in a Human (Mini-) Organ: Nrf2 Activation Protects against Oxidative Stress-Induced Hair Growth Inhibition","volume":"137","author":"Haslam","year":"2017","journal-title":"J. Investig. Dermatol."},{"key":"ref_45","unstructured":"National Research Council (US) (2011). Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals, The National Academies Press. [8th ed.]."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/annonc\/mdh349","article-title":"A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer","volume":"15","author":"Tabernero","year":"2004","journal-title":"Ann. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ctrv.2006.07.003","article-title":"Weekly docetaxel as second line chemotherapy for advanced non-small-cell lung cancer: Meta-analysis of randomized trials","volume":"32","author":"Bria","year":"2006","journal-title":"Cancer Treat. Rev."},{"key":"ref_48","unstructured":"Food and Drug Administration (FDA) (2023, May 24). Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers, Available online: https:\/\/www.fda.gov\/media\/72309\/download."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"303","DOI":"10.4103\/0976-500X.119726","article-title":"How to calculate sample size in animal studies?","volume":"4","author":"Charan","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bbrc.2019.11.100","article-title":"Diethylnitrosamine and thioacetamide-induced hepatic damage and early carcinogenesis in rats: Role of Nrf2 activator dimethyl fumarate and NLRP3 inhibitor glibenclamide","volume":"522","author":"Dwivedi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e174044","DOI":"10.1016\/j.ejphar.2021.174044","article-title":"Activation of the Nrf2\/HO-1 signaling pathway by dimethyl fumarate ameliorates complete Freund\u2019s adjuvant-induced arthritis in rats","volume":"899","author":"Lal","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.fct.2016.12.020","article-title":"Sulforaphane induces differential modulation of mitochondrial biogenesis and dynamics in normal cells and tumor cells","volume":"100","author":"Vega","year":"2017","journal-title":"Food Chem. Toxicol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5859\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:54:39Z","timestamp":1760032479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/12\/5859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":54,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["ijms26125859"],"URL":"https:\/\/doi.org\/10.3390\/ijms26125859","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]}}}